| ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice Q Wang, V Kumar, F Lin, B Sethi, DW Coulter, TR McGuire, RI Mahato Journal of controlled release 323, 463-474, 2020 | 33 | 2020 |
| Recent advances in drug delivery and targeting to the brain B Sethi, V Kumar, K Mahato, DW Coulter, RI Mahato Journal of Controlled Release 350, 668-687, 2022 | 25 | 2022 |
| Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma V Kumar, Q Wang, B Sethi, F Lin, V Kumar, DW Coulter, Y Dong, ... Biomaterials 278, 121138, 2021 | 14 | 2021 |
| Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate V Kumar, B Sethi, E Yanez, DH Leung, YY Ghanwatkar, J Cheong, J Tso, ... International journal of pharmaceutics 615, 121470, 2022 | 8 | 2022 |
| Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice V Kumar, B Sethi, DW Staller, X Xin, J Ma, Y Dong, GA Talmon, RI Mahato Biomaterials 295, 122049, 2023 | 5 | 2023 |
| Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma B Sethi, V Kumar, TD Jayasinghe, Y Dong, DR Ronning, HA Zhong, ... Journal of Controlled Release 354, 80-90, 2023 | 3 | 2023 |
| Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model V Kumar, B Sethi, DW Staller, P Shrestha, RI Mahato Cell Death Discovery 10 (1), 158, 2024 | | 2024 |
| Targeted Therapies for Improving the Treatment of Sonic Hedgehog and MYC Driven Medulloblastoma B Sethi | | 2023 |
| Targeting vismodegib-resistant medulloblastoma using novel hedgehog pathway inhibitor and miR-29b mimic V Kumar, B Sethi, V Kumar, TR Mcguire, DW Coulter, RI Mahato Cancer Research 79 (13_Supplement), 15-15, 2019 | | 2019 |
